EJNMMI Reports

Table 1 Univariate analysis

From: Tumor heterogeneity measurement using [¹⁸F] FDG PET/CT shows prognostic value in patients with non-small cell lung cancer

	Hazard Ratio	p-value	R-sq	C
Age	0.9710	0.8221	0.0005	0.5013
Sex	1.5306	0.1214	0.026	0.5544
SUVmax	1.7746	< 0.0001	0.163	0.6339
StageII^a	9.943	0.0006	0.3387	0.6783
StageIII^a	11.6324	0.0001	0.3387	0.6783
StageIV^a	17.6745	< 0.0001	0.3387	0.6783
HET	1.2363	0.082	0.0293	0.6023

^aClinical Stage for each of stages II-IV is relative to stage I

Back to article page